348 related articles for article (PubMed ID: 32251795)
1. Presepsin values as markers of severity of sepsis.
Aliu-Bejta A; Atelj A; Kurshumliu M; Dreshaj S; Baršić B
Int J Infect Dis; 2020 Jun; 95():1-7. PubMed ID: 32251795
[TBL] [Abstract][Full Text] [Related]
2. [Early diagnostic value of Presepsin in sepsis: a prospective study on a population with suspected sepsis in fever clinics].
Zong X; Liu Y; Gu L; Chen X; Yang C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Apr; 36(4):340-344. PubMed ID: 38813625
[TBL] [Abstract][Full Text] [Related]
3. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy.
Contenti J; Occelli C; Lemoel F; Ferrari P; Levraut J
Emergencias; 2019 Oct; 31(5):311-317. PubMed ID: 31625302
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
[TBL] [Abstract][Full Text] [Related]
5. Presepsin as a predictor of septic shock in patients with urinary tract infection.
Sekine Y; Kotani K; Oka D; Nakayama H; Miyazawa Y; Syuto T; Arai S; Nomura M; Koike H; Matsui H; Shibata Y; Murakami M; Suzuki K
BMC Urol; 2021 Oct; 21(1):144. PubMed ID: 34641833
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions.
Lee S; Song J; Park DW; Seok H; Ahn S; Kim J; Park J; Cho HJ; Moon S
BMC Infect Dis; 2022 Jan; 22(1):8. PubMed ID: 34983420
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.
Liu B; Chen YX; Yin Q; Zhao YZ; Li CS
Crit Care; 2013 Oct; 17(5):R244. PubMed ID: 24138799
[TBL] [Abstract][Full Text] [Related]
8. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
[TBL] [Abstract][Full Text] [Related]
9. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
[TBL] [Abstract][Full Text] [Related]
10. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.
Ruan L; Chen GY; Liu Z; Zhao Y; Xu GY; Li SF; Li CN; Chen LS; Tao Z
Crit Care; 2018 Nov; 22(1):316. PubMed ID: 30463590
[TBL] [Abstract][Full Text] [Related]
11. Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis.
Yoon SH; Kim EH; Kim HY; Ahn JG
BMC Infect Dis; 2019 Aug; 19(1):760. PubMed ID: 31470804
[TBL] [Abstract][Full Text] [Related]
12. The role of plasma presepsin levels in determining the incidence of septic shock and mortality in patients with sepsis.
Kahveci U; Ozkan S; Melekoglu A; Usul E; Ozturk G; Cetin E; Abatay K; Sahin A
J Infect Dev Ctries; 2021 Jan; 15(1):123-130. PubMed ID: 33571154
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S
Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome.
Brodska H; Valenta J; Pelinkova K; Stach Z; Sachl R; Balik M; Zima T; Drabek T
Clin Chem Lab Med; 2018 Mar; 56(4):658-668. PubMed ID: 29176018
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Evaluation of Presepsin with Procalcitonin and CRP in Diagnosing Neonatal Sepsis.
Kumar N; Dayal R; Singh P; Pathak S; Pooniya V; Goyal A; Kamal R; Mohanty KK
Indian J Pediatr; 2019 Feb; 86(2):177-179. PubMed ID: 29577181
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of procalcitonin and C-reactive protein combined with sequential organ failure assessment score in elderly patients with sepsis induced by pulmonary infection].
Qin X; Guo Q; Liu Y; Zhu D; Li J; Zheng D; Tong J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):562-565. PubMed ID: 31198140
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
Kweon OJ; Choi JH; Park SK; Park AJ
J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
[TBL] [Abstract][Full Text] [Related]
20. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study.
Rashwan NI; Hassan MH; Mohey El-Deen ZM; Ahmed AE
Pediatr Neonatol; 2019 Apr; 60(2):149-155. PubMed ID: 29895470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
